Clinical Trial Update: Epigallocatechin Gallate (EGCG) to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) Children [NA]

View source ↗

Summary

A completed clinical trial evaluated whether Epigallocatechin Gallate (EGCG) can improve cognitive performance in children with Fetal Alcohol Syndrome. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Alcohol Syndrome

Drugs mentioned

• Epigallocatechin Gallate (EGCG) (epigallocatechin gallate)

Snippet

Sponsor: Fundacion Clinic per a la Recerca Biomédica | Conditions: Fetal Alcohol Syndrome (FAS) | NA | Status: COMPLETED